ERBB2 and breast carcinoma: Thus, to analyse the contribution of NCAPH expression to the heterogeneous outcome of luminal ERBB2 breast cancer, we used a genetically heterogeneous cohort of MMTV‐ErbB2 transgenic mice generated by backcrossing (BX‐Neu+ mice after that) (Figure 4A).